Bond Biosciences, Inc.
New Filing
CIK: 0001824224·Other Health Care·DELAWARE·Filed: Apr 8, 2026
Total Offering
$15,000,000
Amount Sold
$5,342,880
Investors
64
First Sale
Apr 1, 2026
Offering Details
- Type
- Equity
- Exemptions
- Rule 506(b)
- Entity Type
- Corporation
- Non-Accredited Investors
- No
Related Persons
| Name | Role |
|---|---|
| Michael Beckloff | |
| Cory Berkland | |
| Timothy Opler | |
| Michael A. Riley |
Company
SEC Filing
0001014108-26-000021
View on SEC EDGARWant deeper insights?
Sign up for free to search all filings, track companies, and set up alerts.
Sign Up Free